Thrombectomy in addition to thrombolysis for medium distal vessel occlusions - results from the SITS registry
Authors:
- Boris KeselmanBKBoris Keselman
- Michael MazyaMMMichael Mazya
- Daniel StrbianDSDaniel Strbian
- Ana Paiva NunesANAna Paiva Nunes
- Andrea NaldiANAndrea Naldi
- Danilo ToniDTDanilo Toni
- Marco PetruzzellisMPMarco Petruzzellis
- Giovanni FrisulloGiovanni Frisullo
- Dalius JatuzisDalius Jatuzis
- Niaz AhmedNANiaz Ahmed
- Tiago MoreiraTMTiago Moreira
Preprint
Abstract
Background Endovascular thrombectomy (EVT) is standard of care for acute ischemic stroke (AIS) caused by large vessel occlusion. Medium distal vessel occlusions (MDVO) account for 25-40% AIS cases, but recanalization rates with intravenous thrombolysis (IVT) are often below 50%. Studies have shown mixed results comparing EVT with best medical management in different MDVO populations. This study aims to show if EVT in addition to IVT is associated with clinical benefits or harm in patients with MDVO. Methods We performed an observational study of patients in the Safe Implementation of Treatments of Stroke International Stroke Registry (SITS-ISTR) 2016–23, treated with IVT or IVT+EVT for occlusion of the ACA, PCA or distal MCA (M3 and more distal). Outcomes were modified Rankin Scale score (mRS), death at 3 months, and post-treatment hemorrhage. Inverse probability treatment weighting and binomial logistic regression was performed due to baseline imbalances (age, NIHSS and occlusion site). Results Of 2198 included patients, 1903 (87%) received IVT, and 295 (13%) IVT+EVT. IVT+EVT patients were younger (73 vs 75) and had higher median NIHSS: 10 (IQR 6-15) vs 8 (5-12), pConclusions IVT+EVT for MDVO was associated with worse outcomes compared to IVT alone. Results should be interpreted with caution due to retrospective observational design, warranting further randomized studies, but are in line with recently published RCTsKeywords
This publication has 25 references indexed in Scilit:
- Endovascular thrombectomy for treatment of isolated posterior cerebral artery occlusion: a real-world analysis of hospitalizations in the United StatesActa Neurochirurgica, 2024
- Endovascular thrombectomy for acute ischaemic stroke with established large infarct: multicentre, open-label, randomised trialThe Lancet, 2023
- Trial of Endovascular Thrombectomy for Large Ischemic StrokesNew England Journal of Medicine, 2023
- Endovascular Therapy vs Medical Management for Patients With Acute Stroke With Medium Vessel Occlusion in the Anterior CirculationJAMA Network Open, 2022
- Trial of Thrombectomy 6 to 24 Hours after Stroke Due to Basilar-Artery OcclusionNew England Journal of Medicine, 2022
- Thrombectomy for Primary Distal Posterior Cerebral Artery Occlusion StrokeJAMA Neurology, 2021
- Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion ImagingNew England Journal of Medicine, 2018
- Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and InfarctNew England Journal of Medicine, 2018
- Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trialsThe Lancet, 2016
- Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational studyThe Lancet, 2007